This is not the most recent version of the article. View current version (9 NOV 2011)

Intervention Protocol

H pylori eradication for Parkinson's disease

  1. Karen Rees1,*,
  2. Rebecca Stowe2,
  3. Smitaa Patel3,
  4. Natalie Ives2,
  5. Kieran Breen4,
  6. Carl E Clarke5,
  7. Yoav Ben-Shlomo6

Editorial Group: Cochrane Movement Disorders Group

Published Online: 14 APR 2010

Assessed as up-to-date: 13 AUG 2009

DOI: 10.1002/14651858.CD008453


How to Cite

Rees K, Stowe R, Patel S, Ives N, Breen K, Clarke CE, Ben-Shlomo Y. H pylori eradication for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 4. Art. No.: CD008453. DOI: 10.1002/14651858.CD008453.

Author Information

  1. 1

    Warwick Medical School, University of Warwick, Health Sciences Research Institute, Coventry, UK

  2. 2

    University of Birmingham, Birmingham Clinical Trials Unit, Birmingham, UK

  3. 3

    Robert Aitken Institute, University of Birmingham, Birmingham Clinical Trials Unit, School of Cancer Sciences, Birmingham, UK

  4. 4

    Parkinson's Disease Society, Research and Development Directorate, London, UK

  5. 5

    College of Medicine and Dental Sciences, School of Clinical and Experimental Medicine, Birmingham, West Midlands, UK

  6. 6

    Canynge Hall, Dept of Social Medicine, Bristol, UK

*Karen Rees, Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. Karen.Rees@warwick.ac.uk. rees_karen@yahoo.co.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 14 APR 2010

SEARCH

This is not the most recent version of the article. View current version (09 NOV 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The following questions will be addressed:

1)  What is the prevalence of H pylori in PD patients? We will seek epidemiological studies and recruitment figures for clinical trials will be sought to address this question.

2)  Does treatment of H pylori infection with antibiotics improve symptoms in PD patients? Is this effect dependent on improvements in the absorption of levodopa? We will seek secondary prevention trials will be sought to address this question.